Cargando…

Dialysis outcomes in those aged ≥65 years

BACKGROUND: The number of elderly people over the age of 65 commencing dialysis in NZ has increased by almost 400% in the past decade. Few data are available about health related outcomes and survival on dialysis in the elderly to help the individual, their family, clinicians and health planners wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Robert, Derrett, Sarah, Campbell, John, Marshall, Mark R, Henderson, Andrew, Schollum, John, Williams, Sheila, McNoe, Bronwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765171/
https://www.ncbi.nlm.nih.gov/pubmed/23945009
http://dx.doi.org/10.1186/1471-2369-14-175
_version_ 1782283240000716800
author Walker, Robert
Derrett, Sarah
Campbell, John
Marshall, Mark R
Henderson, Andrew
Schollum, John
Williams, Sheila
McNoe, Bronwen
author_facet Walker, Robert
Derrett, Sarah
Campbell, John
Marshall, Mark R
Henderson, Andrew
Schollum, John
Williams, Sheila
McNoe, Bronwen
author_sort Walker, Robert
collection PubMed
description BACKGROUND: The number of elderly people over the age of 65 commencing dialysis in NZ has increased by almost 400% in the past decade. Few data are available about health related outcomes and survival on dialysis in the elderly to help the individual, their family, clinicians and health planners with decision-making. METHODS/DESIGN: This study will provide the first comprehensive longitudinal survey of health-related quality of life (HRQOL) and other patient centred outcomes for individuals aged ≥65 years on, or eligible for, dialysis therapy and will link these data to survival outcomes. Data collected by yearly structured interviews with participants will be linked to co-morbidity data, health service use, and laboratory information collected from health records, and analysed with respect to HRQOL and survival. The information obtained will inform the delivery of dialysis services in New Zealand and facilitate improved decision-making by individuals, their family and clinicians, about the appropriateness and impact of dialysis therapy on subsequent health and survival. DISCUSSION: Results from this study will make possible more informed decision-making by future elderly patients and their families as they contemplate renal replacement therapy. Results will also allow health professionals to more accurately describe the impact of dialysis therapy on quality of life and outcomes for patients. TRIAL REGISTRATION: ACTRN12611000024943.
format Online
Article
Text
id pubmed-3765171
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37651712013-09-07 Dialysis outcomes in those aged ≥65 years Walker, Robert Derrett, Sarah Campbell, John Marshall, Mark R Henderson, Andrew Schollum, John Williams, Sheila McNoe, Bronwen BMC Nephrol Study Protocol BACKGROUND: The number of elderly people over the age of 65 commencing dialysis in NZ has increased by almost 400% in the past decade. Few data are available about health related outcomes and survival on dialysis in the elderly to help the individual, their family, clinicians and health planners with decision-making. METHODS/DESIGN: This study will provide the first comprehensive longitudinal survey of health-related quality of life (HRQOL) and other patient centred outcomes for individuals aged ≥65 years on, or eligible for, dialysis therapy and will link these data to survival outcomes. Data collected by yearly structured interviews with participants will be linked to co-morbidity data, health service use, and laboratory information collected from health records, and analysed with respect to HRQOL and survival. The information obtained will inform the delivery of dialysis services in New Zealand and facilitate improved decision-making by individuals, their family and clinicians, about the appropriateness and impact of dialysis therapy on subsequent health and survival. DISCUSSION: Results from this study will make possible more informed decision-making by future elderly patients and their families as they contemplate renal replacement therapy. Results will also allow health professionals to more accurately describe the impact of dialysis therapy on quality of life and outcomes for patients. TRIAL REGISTRATION: ACTRN12611000024943. BioMed Central 2013-08-14 /pmc/articles/PMC3765171/ /pubmed/23945009 http://dx.doi.org/10.1186/1471-2369-14-175 Text en Copyright © 2013 Walker et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Protocol
Walker, Robert
Derrett, Sarah
Campbell, John
Marshall, Mark R
Henderson, Andrew
Schollum, John
Williams, Sheila
McNoe, Bronwen
Dialysis outcomes in those aged ≥65 years
title Dialysis outcomes in those aged ≥65 years
title_full Dialysis outcomes in those aged ≥65 years
title_fullStr Dialysis outcomes in those aged ≥65 years
title_full_unstemmed Dialysis outcomes in those aged ≥65 years
title_short Dialysis outcomes in those aged ≥65 years
title_sort dialysis outcomes in those aged ≥65 years
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765171/
https://www.ncbi.nlm.nih.gov/pubmed/23945009
http://dx.doi.org/10.1186/1471-2369-14-175
work_keys_str_mv AT walkerrobert dialysisoutcomesinthoseaged65years
AT derrettsarah dialysisoutcomesinthoseaged65years
AT campbelljohn dialysisoutcomesinthoseaged65years
AT marshallmarkr dialysisoutcomesinthoseaged65years
AT hendersonandrew dialysisoutcomesinthoseaged65years
AT schollumjohn dialysisoutcomesinthoseaged65years
AT williamssheila dialysisoutcomesinthoseaged65years
AT mcnoebronwen dialysisoutcomesinthoseaged65years